Journal of Cardiovascular Pharmacology and Therapeutics

Papers
(The TQCC of Journal of Cardiovascular Pharmacology and Therapeutics is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management71
Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-1931
A Comprehensive Review of PCSK9 Inhibitors30
Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data26
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights24
The JUUL E-Cigarette Elevates the Risk of Thrombosis and Potentiates Platelet Activation22
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart22
Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice18
Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes?18
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Di17
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database17
A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine16
Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways16
The Role of Natriuretic Peptides in the Regulation of Cardiac Tolerance to Ischemia/Reperfusion and Postinfarction Heart Remodeling16
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Ezetimibe on Risk of New-Onset Diabetes: A Systematic Review and Meta-Analysis of Large, Double-Blinded Randomized Controlled Trials15
Aspirin Is Associated With Reduced Rates of Venous Thromboembolism in Older Patients With Cancer15
Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis15
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men14
Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data14
COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges13
Diabetes Mellitus and Noncardiac Atherosclerotic Vascular Disease—Pathogenesis and Pharmacological Treatment Options13
Age-Related Considerations in Cardio-Oncology13
Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use13
Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection12
Machine Learning in Cardiology—Ensuring Clinical Impact Lives Up to the Hype12
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study12
The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction12
Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study12
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension11
Hydrogen Sulfide Therapy Suppresses Cofilin-2 and Attenuates Ischemic Heart Failure in a Mouse Model of Myocardial Infarction11
Umbrella Review on Non-Statin Lipid-Lowering Therapy11
Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms10
Fondaparinux Sodium: Recent Advances in the Management of Thrombosis9
COVID-19: The Heart of the Matter—Pathological Changes and a Proposed Mechanism9
The Future of Cardioprotection—Pointing Toward Patients at Elevated Risk as the Target Populations9
Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction9
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI Registry8
Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury8
Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation8
The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead7
Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction7
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review7
Left Ventricular Thrombus Therapy With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review and Meta-Analysis7
CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial7
Nucleolin Improves Heart Function During Recovery From Myocardial Infarction by Modulating Macrophage Polarization7
0.024045944213867